Vector-borne diseases (VBDs) pose significant public health challenges in India, accounting for more than 10% of the country's disease burden. The widespread occurrence of these diseases is largely attributed to environmental factors and socio-economic disparities.
Malaria, dengue, and chikungunya are the most prevalent VBDs in India. Malaria alone accounts for 89% of the South-East Asia Region's burden. Dengue, with its explosive outbreaks, is now endemic in all states. Meanwhile, chikungunya, although less prevalent, has seen an increase in cases over the past decade.
Management of VBDs in India faces numerous challenges. These include inadequate surveillance, lack of public awareness, and limited resources for vector control. Additionally, climate change and urbanization exacerbate the spread of vectors, making control measures more difficult.
Integrated Vector Management (IVM) is advocated by the World Health Organization (WHO) for the control of VBDs. This approach combines methods to control vector populations and reduce disease transmission. It emphasizes sustainability, cost-effectiveness, and ecological soundness. In India, enhancing surveillance systems, improving diagnostic facilities, and strengthening health infrastructure are vital components of IVM.
Healthcare professionals play a crucial role in managing VBDs. Their responsibilities range from early detection and treatment to educating the public about prevention methods. Furthermore, their involvement in research can contribute to the development of new strategies for VBD control.
The burden of VBDs in India is significant, but with concerted efforts from healthcare professionals, policymakers, and the community, it can be effectively managed. By adopting comprehensive strategies such as IVM and strengthening healthcare infrastructure, India can make substantial progress in controlling VBDs.
1.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
2.
Nodal Response After Chemo Helps Tailor Breast Radiotherapy
3.
For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.
4.
In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.
5.
Common intracellular toxin could help fight leukemia
1.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
2.
Clonal Hematopoiesis and Thrombotic Risk Beyond Cancer: A Comprehensive Review for Clinicians
3.
Unlocking The Causes And Risk Factors Of Breast Cancer
4.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
5.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Thromboprophylaxis In Medical Settings
2.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
3.
How Multidisciplinary Teams Support Modern Cancer Care
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation